India-Upper Rhine Region Softlanding Programme

• 
• 
• 

Selected Startups for the 2026 Cohort

Intignus Biotech Pvt Ltd

A healthcare startup focused on advancing innovative solutions in women’s health by early detection of pregnancy complications. Through their product, PEscreen, a rapid biomarker-based screening test designed for early risk stratification of preeclampsia during pregnancy, they aim to enable timely intervention and improve maternal and fetal outcomes.

Kozhnosys Pvt Ltd

Kozhnosys is a medtech company developing portable, non‑invasive accurate breath analyzers for early disease detection. It delivers rapid breast cancer screening results without a doctor through its non‑invasive product, Canscan, which detects volatile organic compounds in exhaled breath. Its portability and patient-friendly design make it easy to use, transforming how women approach preventive healthcare by enabling early detection and improving accessibility to breast cancer diagnostics.

Fontierz Pvt Ltd

Fontierz develops advanced surgical power tools and motion control systems, including arthroscopic shavers, high-speed spine systems, endoscopic spine burrs, and atherectomy devices for robotic surgical applications. Built on deep expertise in embedded electronics and multi-axis robotics, Fontierz delivers precision-engineered solutions that empower surgeons with reliable, high-performance instruments, bridging cutting-edge motion control technology with real-world clinical needs.

NanoTheraPx Innovations Pvt Ltd

NanoTherapX is developing PsorisCare, a patented plant-based nanogel, delivering steroid-free, affordable psoriasis care. The formulation uses lipid nanoparticle technology to enhance skin penetration and provide sustained therapeutic action without steroids. It aims to offer a safe, affordable, and scalable alternative to current psoriasis therapies, improving patient adherence and long-term outcomes

AeroDel Technology Innovations Pvt Ltd

AeroDel focuses on improving patient experience for respiratory patients. Through innovations, such as ‘AeroFlex’, a patented companion device to enhance the efficiency of metered-dose inhaler; ‘JetMist’, a portable  jet-powered nebulizer; and ‘ActiveControl’ a smart sensor-enabled pMDI add-on for technique correction, adherence monitoring, and early exacerbation warning, they are simplifying inhalation for Asthma and respiratory patients and reducing preventable deaths. AeroDel’s flagship commercial partnership with Zydus Lifesciences anchors its go-to-market in India, with an expanding pipeline of pharma and research collaborations for global markets.

Diagopreutic Pvt Ltd

Diagopreutic offers 18 patented, CDSCO-approved antimicrobial susceptibility testing (AST) kits, clinically validated with 95% sensitivity and 98% specificity. Delivering accurate results at the point of care in under 6 hours, they help infectious disease physicians and microbiology labs identify the right antibiotic for the right patient so that clinicians can save lives before resistance wins.

ForschMedX

ForschMedX, a healthcare innovation company is building ‘TrachEase’, a smart airway hygiene system that automates suctioning and blockage detection for safer ventilation in ICU patients. By combining a redesigned airway interface, intelligent suction control, and sensing, TrachEase aims to reduce airway emergencies, lower complication risk, and ease the burden on ICU teams.

Pacify Medical Technologies Pvt Ltd

Pacify Medical aims to make advanced trauma care accessible with the portable ‘Skin Spray Gun’, a device that atomizes the patient’s own skin into a fine mist for rapid grafting during wound treatment. Unlike traditional invasive surgery, this technology requires 10x less donor skin, reducing patient trauma and recovery time. Pacify Medical is revolutionizing wound care by bridging the gap between complex regenerative medicine and affordable hardware, making advanced trauma care accessible to rural hospitals.

Serigen Mediproducts Pvt. Ltd.

Serigen focuses on innovative tissue regeneration products that serve diverse clinical needs. Its silk microparticle based osteoconductive bone void filler, ‘Serioss’ fills cavities in bone caused by trauma, infection, cancer, etc. and provides the optimal environment for bone cells to thrive and function. Serioss addresses the unmet need for a synthetic bone void filler with the performance of an autograft.

Explore the Participant Profiles here.